Related Experiment Video

Updated: Aug 19, 2025

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
05:53

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates

Published on: July 6, 2013

15.1K

Managing challenges in congenital CMV: current thinking

Christine E Jones1,2, Heather Bailey3, Alasdair Bamford4,5

  • 1Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK c.e.jones@soton.ac.uk.

Archives of Disease in Childhood
|November 28, 2022
PubMed

Insights

Congenital cytomegalovirus (CMV) infection is common and can cause lifelong issues in infants. Early diagnosis and treatment are crucial for better outcomes, yet awareness remains low among the public and healthcare providers.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Congenital human cytomegalovirus (CMV) is the most frequent congenital infection, impacting approximately 1 in 200 infants in high-income countries.
  • This infection can lead to severe, lifelong consequences in up to 25% of affected children, including neurodevelopmental disabilities and sensorineural hearing loss.
  • Despite its prevalence and potential severity, congenital CMV remains poorly recognized by pregnant women, families, and healthcare professionals.

Purpose of the Study:

  • To highlight the significance of timely diagnosis of CMV infection during pregnancy for potential treatment with valaciclovir.
  • To emphasize the importance of recognizing congenital CMV symptoms for prompt neonatal testing within 21 days of life.
  • To underscore the need for early diagnosis to enable appropriate valganciclovir treatment for affected infants, aiming to improve their health outcomes.

Main Methods:

  • The abstract does not detail specific methods but discusses the importance of diagnosis and treatment timing.
  • It emphasizes clinical recognition of congenital CMV features by specialists.
  • It calls for further research into screening, outcomes, and treatment.

Main Results:

  • The abstract does not present study results but highlights the potential benefits of early diagnosis and treatment.
  • Valaciclovir treatment during pregnancy may reduce fetal transmission or disease severity.
  • Valganciclovir treatment in neonates can improve outcomes for infants with congenital CMV.

Conclusions:

  • Congenital CMV is a common yet under-recognized condition with significant potential for long-term infant morbidity.
  • Early diagnosis and intervention are critical for managing congenital CMV and improving infant outcomes.
  • Further research is essential to guide screening strategies, understand long-term effects, and optimize treatment protocols.

Keywords:
Infectious Disease MedicineNeonatology

More Related Videos

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain05:51

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Published on: July 24, 2016

19.7K
Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

12.5K

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
210
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
25
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
25
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
26